The role of mesenchymal stem cells in haemopoiesis

Blood Reviews

Volumn 20, Issue 3, 2006, Pages 161-171

  Dazzi, Francesco ^a   Ramasamy, Rajesh ^a   Glennie, Sarah ^a   Jones, Simon P ^a   Roberts, Irene ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Fetal and adult haemopoiesis; Haemopoietic niche; Mesenchymal stem cells; Stroma

Indexed keywords

ANIMALS; CELL DIVISION; CHEMOKINES; CYTOKINES; HEMATOPOIESIS; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; LYMPHOPOIESIS; MESENCHYMAL STEM CELLS;

EID: 33646015065     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2005.11.002     Document Type: Article

References (121)

1. Kadiyala S., Young R.G., Thiede M.A., and Bruder S.P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6 (1997) 125-134
2. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
3. Koc O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
4. Horwitz E.M., Gordon P.L., Koo W.K., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99 (2002) 8932-8937
5. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
6. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., and Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20 (2002) 530-541
7. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
8. Zappia E., Casazza S., Pedemonte E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood (2005)
9. Baddoo M., Hill K., Wilkinson R., et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89 (2003) 1235-1249
10. Santa Maria L., Rojas C.V., and Minguell J.J. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp Cell Res 300 (2004) 418-426
11. Devine S.M., Bartholomew A.M., Mahmud N., et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29 (2001) 244-255
12. Airey J.A., Almeida-Porada G., Colletti E.J., et al. Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation 109 (2004) 1401-1407
13. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
14. Moscoso I., Centeno A., Lopez E., et al. Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc 37 (2005) 481-482
15. Bosnakovski D., Mizuno M., Kim G., Takagi S., Okumura M., and Fujinaga T. Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell Tissue Res 319 (2005) 243-253
16. Ringe J., Haupl T., and Sittinger M. Mesenchymal stem cells for tissue engineering of bone and cartilage. Med Klin (Munich) 98 Suppl 2 (2003) 35-40
17. Villaron E.M., Almeida J., Lopez-Holgado N., et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 89 (2004) 1421-1427
18. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
19. in't Anker P.S., Noort W.A., Scherjon S.A., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88 (2003) 845-852
20. Igura K., Zhang X., Takahashi K., Mitsuru A., Yamaguchi S., and Takashi T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6 (2004) 543-553
21. Tsai M.S., Lee J.L., Chang Y.J., and Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19 (2004) 1450-1456
22. Erices A., Conget P., and Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109 (2000) 235-242
23. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2 (2000) 477-488
24. O'Donoghue K., Choolani M., Chan J., et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod 9 (2003) 497-502
25. O'Donoghue K., Chan J., de la Fuente J., et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364 (2004) 179-182
26. Kuznetsov S.A., Friedenstein A.J., and Robey P.G. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97 (1997) 561-570
27. Gronthos S., and Simmons P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85 (1995) 929-940
28. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., and Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98 (2001) 2615-2625
29. Colter D.C., Class R., DiGirolamo C.M., and Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 97 (2000) 3213-3218
30. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 100 Suppl 1 (2003) 11917-11923
31. Bruder S.P., Jaiswal N., and Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64 (1997) 278-294
32. Colter D.C., Sekiya I., and Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98 (2001) 7841-7845
33. Gregory C.A., Singh H., Perry A.S., and Prockop D.J. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278 (2003) 28067-28078
34. Krampera M., Pasini A., Rigo A., et al. HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation. Blood (2005)
35. Simmons P.J., and Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78 (1991) 55-62
36. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B., and Gallatin W.M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80 (1992) 388-395
37. Alsalameh S., Amin R., Gemba T., and Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50 (2004) 1522-1532
38. Silva Jr. W.A., Covas D.T., Panepucci R.A., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21 (2003) 661-669
39. Monticone M., Liu Y., Tonachini L., et al. Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysis. J Cell Biochem 92 (2004) 733-744
40. Jeong J.A., Hong S.H., Gang E.J., et al. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 23 (2005) 584-593
41. Panepucci R.A., Siufi J.L., Silva Jr. W.A., et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22 (2004) 1263-1278
42. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow-derived stem cells. Blood 102 (2003) 3483-3493
43. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., and Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 (2002) 337-346
44. Woodbury D., Schwarz E.J., Prockop D.J., and Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61 (2000) 364-370
45. Sato Y., Araki H., Kato J., et al. Human mesenchymal stem cells xenografted directly to rat liver differentiated into human hepatocytes without fusion. Blood (2005)
46. Togel F., Hu Z., Weiss K., et al. Amelioration of Acute Renal Failure by Stem Cell Therapy-Paracrine Secretion Versus Transdifferentiation into Resident Cells: Administered Mesenchymal Stem Cells Protect against Ischemic Acute Renal Failure through Differentiation-Independent Mechanisms. Am J Physiol Renal Physiol E-pub February 15, 2005. J Am Soc Nephrol 16 (2005) 1153-1163
47. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
48. Egusa H., Schweizer F.E., Wang C.C., Matsuka Y., and Nishimura I. Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing. J Biol Chem (2005)
49. Shizuru J.A., Negrin R.S., and Weissman I.L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56 (2005) 509-538
50. de Bruijn M.F., Speck N.A., Peeters M.C., and Dzierzak E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. Embo J 19 (2000) 2465-2474
51. Marshall C.J., and Thrasher A.J. The embryonic origins of human haematopoiesis. Br J Haematol 112 (2001) 838-850
52. Dzierzak E. The emergence of definitive hematopoietic stem cells in the mammal. Curr Opin Hematol 12 (2005) 197-202
53. Kumaravelu P., Hook L., Morrison A.M., et al. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development 129 (2002) 4891-4899
54. Ling K.W., Ottersbach K., van Hamburg J.P., et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med 200 (2004) 871-882
55. Gekas C., Dieterlen-Lievre F., Orkin S.H., and Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev Cell 8 (2005) 365-375
56. Ottersbach K., and Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell 8 (2005) 377-387
57. Klein A.K., Dyck J.A., Stitzel K.A., Shimizu J., Fox L.A., and Taylor N. Characterization of canine fetal lymphohematopoiesis: studies of CFUGM, CFUL, and CFUF. Exp Hematol 11 (1983) 263-274
58. Van den Heuvel R.L., Versele S.R., Schoeters G.E., and Vanderborght O.L. Stromal stem cells (CFU-f) in yolk sac, liver, spleen and bone marrow of pre- and postnatal mice. Br J Haematol 66 (1987) 15-20
59. Charbord P., Tavian M., Humeau L., and Peault B. Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood 87 (1996) 4109-4119
60. Mendes S.C., Robin C., and Dzierzak E. Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development 132 (2005) 1127-1136
61. Friedenstein A.J., Piatetzky S., and Petrakova II K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16 (1966) 381-390
62. Noort W.A., Kruisselbrink A.B., in't Anker P.S., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 (+) cells in NOD/SCID mice. Exp Hematol 30 (2002) 870-878
63. Zhang Y., Adachi Y., Suzuki Y., et al. Simultaneous injection of bone marrow cells and stromal cells into bone marrow accelerates hematopoiesis in vivo. Stem Cells 22 (2004) 1256-1262
64. Dexter T.M., Allen T.D., and Lajtha L.G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91 (1977) 335-344
65. Sugiura K., Hisha H., Ishikawa J., et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Stem Cells 19 (2001) 46-58
66. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients. Biol Blood Marrow Transplant 11 (2005) 389-398
67. Bianco P., and Boyde A. Confocal images of marrow stromal (Westen-Bainton) cells. Histochemistry 100 (1993) 93-99
68. Bianco P., Riminucci M., Kuznetsov S., and Robey P.G. Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 9 (1999) 159-173
69. Bianco P., Costantini M., Dearden L.C., and Bonucci E. Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 68 (1988) 401-403
70. Wilson C.A., Bekele G., Nicolson M., Ravussin E., and Pratley R.E. Relationship of the white blood cell count to body fat: role of leptin. Br J Haematol 99 (1997) 447-451
71. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
72. Li W., Johnson S.A., Shelley W.C., and Yoder M.C. Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp Hematol 32 (2004) 1226-1237
73. Gaugler M.H., Squiban C., Mouthon M.A., Gourmelon P., and van der Meeren A. Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells. Br J Haematol 113 (2001) 940-950
74. Cannella L., Laylor R., Marelli-Berg F., and Dazzi F. Irradiation influences endothelial cell function in vitro and in vivo: A possible role for IP10. Biology of Blood and Marrow Transplantation 11 (2005) 45
75. Arai F., Hirao A., and Suda T. Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc Med 15 (2005) 75-79
76. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
77. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
78. Lord B.I., Testa N.G., and Hendry J.H. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46 (1975) 65-72
79. Balduino A., Hurtado S.P., Frazao P., et al. Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations. Cell Tissue Res 319 (2005) 255-266
80. Eglitis M.A., and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94 (1997) 4080-4085
81. Camargo F.D., Green R., Capetanaki Y., Jackson K.A., and Goodell M.A. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 9 (2003) 1520-1527
82. Stein M.I., Zhu J., and Emerson S.G. Molecular pathways regulating the self-renewal of hematopoietic stem cells. Exp Hematol 32 (2004) 1129-1136
83. Reya T., Duncan A.W., Ailles L., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
84. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10 (2004) 55-63
85. Duncan A.W., Rattis F.M., DiMascio L.N., et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6 (2005) 314-322
86. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
87. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10 (2004) 64-71
88. Banu N., Avraham S., and Avraham H.K. P-selectin, and not E-selectin, negatively regulates murine megakaryocytopoiesis. J Immunol 169 (2002) 4579-4585
89. Hurley R.W., McCarthy J.B., and Verfaillie C.M. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96 (1995) 511-519
90. Jiang Y., Prosper F., and Verfaillie C.M. Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. Blood 95 (2000) 846-854
91. Glennie S., Soeiro I., Dyson P.J., Lam E.W., and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105 (2005) 2821-2827
92. Haynesworth S.E., Baber M.A., and Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166 (1996) 585-592
93. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., and Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176 (1998) 57-66
94. Roberts I. Mesenchymal stem cells. Vox Sang 87 Suppl 2 (2004) 38-41
95. Majumdar M.K., Thiede M.A., Haynesworth S.E., Bruder S.P., and Gerson S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9 (2000) 841-848
96. Taichman R.S., Reilly M.J., Verma R.S., and Emerson S.G. Augmented production of interleukin-6 by normal human osteoblasts in response to CD34+ hematopoietic bone marrow cells in vitro. Blood 89 (1997) 1165-1172
97. Ahmed N., Sammons J., Carson R.J., Khokher M.A., and Hassan H.T. Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow stroma. Cell Biol Int 25 (2001) 429-435
98. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
99. Auerbach R. Morphogenetic interactions in the development of the mouse thymus gland. Dev Biol 2 (1960) 271-284
100. Bockman D.E., and Kirby M.L. Dependence of thymus development on derivatives of the neural crest. Science 223 (1984) 498-500
101. Anderson G., and Jenkinson E.J. Lymphostromal interactions in thymic development and function. Nat Rev Immunol 1 (2001) 31-40
102. Revest J.M., Suniara R.K., Kerr K., Owen J.J., and Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 167 (2001) 1954-1961
103. Jenkinson W.E., Jenkinson E.J., and Anderson G. Differential requirement for mesenchyme in the proliferation and maturation of thymic epithelial progenitors. J Exp Med 198 (2003) 325-332
104. Banwell C.M., Partington K.M., Jenkinson E.J., and Anderson G. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur J Immunol 30 (2000) 2125-2129
105. Dejbakhsh-Jones S., Jerabek L., Weissman I.L., and Strober S. Extrathymic maturation of alpha beta T cells from hemopoietic stem cells. J Immunol 155 (1995) 3338-3344
106. Li Y., Hisha H., Inaba M., et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp Hematol 28 (2000) 950-960
107. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
108. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
109. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003) 3722-3729
110. Potian J.A., Aviv H., Ponzio N.M., Harrison J.S., and Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171 (2003) 3426-3434
111. Otten G.R., and Germain R.N. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251 (1991) 1228-1231
112. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., and Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389-397
113. Djouad F., Plence P., Bony C., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837-3844
114. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
115. Beyth S., Borovsky Z., Mevorach D., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214-2219
116. Zhang W., Ge W., Li C., et al. Effects of Mesenchymal Stem Cells on Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells. Stem Cells Dev 13 (2004) 263-271
117. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
118. Jiang X.X., Zhang Y., Liu B., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120-4126
119. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5 (1999) 309-313
120. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30 (2002) 215-222
121. Frassoni F.L.M., Bacigalupo A., Gluckman E., Rocha V., Bruno B., Lazarus H., et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant 29 (2002) 75